Melbourne, Australia – An innovative technology that captures high-quality images of a tumour in six seconds is being used to guide cancer treatments for patients receiving care at the Icon Cancer Centre Holmesglen.
Introducing HyperSight at Icon Cancer Centre Australia
A new cutting-edge cancer imaging tool allows doctors to efficiently adapt radiation therapy treatment.
Icon is one of the first centres in the South Hemisphere to install Varian’s HyperSight. HyperSight uses cone-beam computed tomography (CBCT) to deliver images with a high level of contrast. It can capture a larger area with improved image quality, precision, and speed compared to conventional imaging technology on radiation therapy systems, potentially minimizing patient discomfort and anxiety during treatment.
Traditional radiation therapy imaging systems can take up to 60 seconds and can require patients to hold their breath to capture a clear image. This is to prevent the tumour from moving during the scan, which is common in lung, liver, and left breast cancer patients. HyperSight is designed to reduce motion-related image blurring, resulting in clearer images at the point of treatment.
Data from HyperSight images show how radiation therapy treatment is changing the tumour and surrounding anatomy. The enhanced quality of CBCT images can be used to calculate changes to both the tumour and nearby organs with greater precision. Previously, calculations were limited by image quality or required a CT scan on a separate machine, potentially adding to the time the patient needs to stay in hospital.
Icon Group Director of Radiation Therapy, Claire Smith, said the technology is making a difference.
“We can pinpoint and map tumours in the patient almost in real time,” said Claire.
“In its early stages, we’re already seeing great benefits for our clinical teams and patients and are looking forward to rolling out HyperSight across Australia cancer centres, and beyond.”
“We are still assessing the impact it is having on our clinical workflows, like preventing unnecessary trips to a CT scanner, and reducing the time a patient needs to be on the treatment bed. Having this capability on the machine in the treatment room is already proving positive with our radiation therapists.”
“Our global collaboration with Varian helps us remain well equipped to provide our patients with the latest in radiation therapy treatments. Our goal is to deliver the best possible care and a better quality of life.”
HyperSight was developed by Varian, a Siemens Healthineers company. It received TGA approval for use on Varian’s Ethos and Halcyon image-guided radiation therapy systems in February this year.
VARIAN, HYPERSIGHT, ETHOS, and HALCYON are trademarks of Varian Medical Systems, Inc., pending or registered U.S. Pat. & Tm. Off.
A career with Icon
At Icon, you’ll help change lives, every single day. In return for your passion, dedication and agility, we offer a workplace where you can.
Fifth Icon Cancer Centre opens in China
Read more about our latest radiation oncology service in Mainland China
Icon Cancer Centre
Learn more about our cancer centre network in Australia
Updates
Read the latest news and updates across Icon Group